Consistently, pretreatment with fatostatin or TVB‐3166, which are pharmacological inhibitors of SREBP‐1 and FASN, respectively, also impeded cancer cell growth promoted by leptin (Fig. 6C,D). This evidence concerns the gene LEP and cancer.